OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2016
(2)
2026
(1)
2025
(1)
2023
(1)
2022
(1)
2021
(1)
2020
(1)
2019
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Not available
S-EPMC5302970
|
biostudies-literature
Cite
Designing a Person-Centred Integrated Care Programme for People with Complex Chronic Conditions: A Case Study from Catalonia.
Not available
S-EPMC8622001
|
biostudies-literature
Cite
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
Not available
S-EPMC9641781
|
biostudies-literature
Cite
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
Not available
S-EPMC5348364
|
biostudies-literature
Cite
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Not available
S-EPMC10569976
|
biostudies-literature
Cite
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.
Not available
S-EPMC12925033
|
biostudies-literature
Cite
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.
Not available
S-EPMC6934558
|
biostudies-literature
Cite
A machine learning approach to identify patients at risk for long-term consequences after pulmonary embolism.
Not available
S-EPMC12460599
|
biostudies-literature
Cite
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.
Not available
S-EPMC7734592
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets